Methyl2-(morpholin-3-yl)acetatehydrochloride, 97%, 1g

Hexyl Methyl Ether>98.0%(GC)100mL

2-Methyl tetrahydro-3-furanone, 95.0%, 5g

tert-Butyl ((3R,4R)-4-aminotetrahydro-2H-pyran-3-yl)carbamate, 95.0%, 5g

(2R,4R)-tert-Butyl 2-(fluoromethyl)-4-hydroxypyrrolidine-1-carboxylate, 95+%, 1g

3-(4-(3,6,9,12-Tetraoxapentadec-14-yn-1-yloxy)phenyl)-6-methyl-1,2,4,5-tetrazine, 95%, 50mg

1,7-Dibromoheptane, 95.0%, 10g

3,3-Dimethylcyclobutanecarboxylic acid, 95.0%, 25g

ETHYL 6-HYDROXY-1H-PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXYLATE, 95.0%, 25g

(E)-(2-Nitrovinyl)benzene, 98.0%, 25g

anti-DDDDK-tag mouse monoclonal, AP1501, 25 µg

2-(Methylthio)benzo[d]oxazole, 95.0%, 100g

N-Methyl-L-proline, 95.0%, 10g